Market Share of Asia-Pacific Cancer Biomarkers Industry
The Asia-Pacific cancer biomarkers market is fragmented due to the presence of several market players. These players are focusing on R&D, market expansions, partnerships, and mergers to experience stable growth. Some of the key players in the Asia-Pacific cancer biomarkers market are Abbott Laboratories Inc., Thermo Fisher Scientific, Agilent Technologies, Biomerieux SA, and Celera Corporation (Quest Diagnostics), among others.
Asia-Pacific Cancer Biomarkers Market Leaders
Abbott Laboratories Inc.
Biomerieux
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific
Qiagen NV
*Disclaimer: Major Players sorted in no particular order
